Search

Author/Creator Janning, M.

1. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells. Issue 12 (26th February 2016)

Authors:
Hvichia, G.E.; Parveen, Z.; Wagner, C.; Janning, M.; Quidde, J.; Stein, A.; Müller, V.; Loges, S.; Neves, R.P.L.; Stoecklein, N.H.; Wikman, H.; Riethdorf, S.; Pantel, K.; Gorges, T.M.
Journal:
International journal of cancer
Issue:
Volume 138:Issue 12(2016:Jun. 15)
Page Start:
2894
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P548: BEMCENTINIB COMBINED WITH LOW-DOSE CYTARABINE IS EFFICACIOUS AND WELL TOLERATED IN RELAPSED AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY. UPDATES FROM THE ONGOING PHASE II TRIAL (NCT02488408). (23rd June 2022)

Authors:
Loges, S.; Heuser, M.; Chromik, J.; Sutamtewagul, G.; Kapp-Schwoerer, S.; Crugnola, M.; Di Renzo, N.; Lemoli, R.; Mattei, D.; Ben-Batalla, I.; Waizenegger, J.; Rieckmann, L.-M.; Janning, M.; Imbusch, C. D.; Beumer, N.; Micklem, D.; Gorcea-Carson, C.; Lawson, G.; Nautiyal, J.; Deharo, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing. (October 2020)

Authors:
Christopoulos, P.; Kirchner, M.; Roeper, J.; Saalfeld, F.; Janning, M.; Bozorgmehr, F.; Magios, N.; Kazdal, D.; Volckmar, A.L.; Brückner, L.M.; Bochtler, T.; Kriegsmann, M.; Endris, V.; Penzel, R.; Kriegsmann, K.; Eichhorn, M.; Herth, F.J.F.; Heussel, C.P.; El Shafie, R.A.; Schneider, M.A.
Journal:
Lung cancer
Issue:
Volume 148(2020)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗